BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26141711)

  • 1. Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies.
    Wu L; Zhu J
    Hum Reprod; 2015 Sep; 30(9):2234-40. PubMed ID: 26141711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breastfeeding and thyroid cancer risk in women: A dose-response meta-analysis of epidemiological studies.
    Yi X; Zhu J; Zhu X; Liu GJ; Wu L
    Clin Nutr; 2016 Oct; 35(5):1039-46. PubMed ID: 26732028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and cancer of the cervix uteri. A meta-analysis.
    Delgado-Rodriguez M; Sillero-Arenas M; Martin-Moreno JM; Galvez-Vargas R
    Acta Obstet Gynecol Scand; 1992 Jul; 71(5):368-76. PubMed ID: 1326213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-analysis of epidemiological studies.
    Luan NN; Wu L; Gong TT; Wang YL; Lin B; Wu QJ
    Cancer Causes Control; 2015 Jan; 26(1):65-78. PubMed ID: 25359305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis.
    Vercellini P; Consonni D; Dridi D; Bracco B; Frattaruolo MP; Somigliana E
    Hum Reprod; 2014 May; 29(5):964-77. PubMed ID: 24622619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive use and kidney cancer risk among women: evidence from a meta-analysis.
    Liu H; Wang XC; Hu GH; Huang TB; Xu YF
    Int J Clin Exp Med; 2014; 7(11):3954-63. PubMed ID: 25550903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis.
    Bosetti C; Bravi F; Negri E; La Vecchia C
    Hum Reprod Update; 2009; 15(5):489-98. PubMed ID: 19414526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between oral contraceptive use and pancreatic cancer risk: A systematic review and meta-analysis.
    Ilic M; Milicic B; Ilic I
    World J Gastroenterol; 2021 May; 27(20):2643-2656. PubMed ID: 34092981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies.
    Zhu H; Lei X; Feng J; Wang Y
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):402-14. PubMed ID: 23061743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of protective effect of oral contraceptive use on the development of rheumatoid arthritis: a meta-analysis of observational studies.
    Chen Q; Jin Z; Xiang C; Cai Q; Shi W; He J
    Int J Rheum Dis; 2014 Sep; 17(7):725-37. PubMed ID: 25196669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis.
    Maheux-Lacroix S; Boutin A; Moore L; Bergeron ME; Bujold E; Laberge P; Lemyre M; Dodin S
    Hum Reprod; 2014 May; 29(5):953-63. PubMed ID: 24578476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Caesarean section on subsequent fertility: a systematic review and meta-analysis.
    Gurol-Urganci I; Bou-Antoun S; Lim CP; Cromwell DA; Mahmood TA; Templeton A; van der Meulen JH
    Hum Reprod; 2013 Jul; 28(7):1943-52. PubMed ID: 23644593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity and thyroid cancer risk: a meta-analysis of epidemiological studies.
    Zhu J; Zhu X; Tu C; Li YY; Qian KQ; Jiang C; Feng TB; Li C; Liu GJ; Wu L
    Cancer Med; 2016 Apr; 5(4):739-52. PubMed ID: 26714593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis.
    Peng Y; Wang X; Feng H; Yan G
    J Obstet Gynaecol Res; 2017 May; 43(5):913-922. PubMed ID: 28759170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies.
    Jing Z; Hou X; Liu Y; Yan S; Wang R; Zhao S; Wang Y
    Int J Cancer; 2015 Sep; 137(6):1484-90. PubMed ID: 25693727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial oocyte activation to improve reproductive outcomes in women with previous fertilization failure: a systematic review and meta-analysis of RCTs.
    Sfontouris IA; Nastri CO; Lima ML; Tahmasbpourmarzouni E; Raine-Fenning N; Martins WP
    Hum Reprod; 2015 Aug; 30(8):1831-41. PubMed ID: 26082476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.